ANALYSIS OF DEFERASIROX AND DEFERIPRON USE IN CHILDREN WITH PEDIATRIC -THALASSEMIA MAJOR

ANALYSIS OF DEFERASIROX AND DEFERIPRON USE IN CHILDREN WITH PEDIATRIC -THALASSEMIA MAJOR

b-thalassemia major is a genetic disease and a decline in production due to imperfect of hemoglobin. Clinical manifestations are anemia, treated with regular blood transfusions. Blood transfusions lead to an increase in iron in the body that can lead to organ complications. Iron chelation drug deliv...

Full description

Bibliographic Details
Main Authors: Evy Sari Sutrisnaningsih, Suharjono Suharjono, Bambang Sudarmanto
Format: Article
Language:English
Published: Universitas Airlangga 2017-08-01
Series:Folia Medica Indonesiana
Subjects:
-thalassemia mayor, childern, deferasirox, deferipron
Online Access:https://e-journal.unair.ac.id/FMI/article/view/5207

Similar Items

Similar Items